| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.27 | 2e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.21 | 0.0006 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.074 | 0.2 |